(PLXS) Plexus - Ratings and Ratios
Manufacturing, Design, Supply, Services, Medical
PLXS EPS (Earnings per Share)
PLXS Revenue
Description: PLXS Plexus
Plexus Corp is a leading provider of electronic manufacturing services (EMS) globally, catering to diverse market sectors including aerospace/defense, healthcare/life sciences, industrial/commercial, and communications. The companys comprehensive suite of services encompasses design, development, supply chain management, new product introduction, and manufacturing solutions, as well as sustaining services, making it a one-stop-shop for clients.
With a strong presence in the EMS industry, Plexus Corp has established a reputation for delivering high-quality products and services. Key performance indicators (KPIs) such as revenue growth, gross margin, and operating margin are crucial in evaluating the companys financial health. Notably, Plexus Corp has consistently demonstrated a gross margin above 9%, indicating its ability to maintain profitability. Additionally, the companys return on equity (RoE) of 12.37% suggests effective utilization of shareholder capital.
To further assess Plexus Corps performance, other relevant KPIs include its debt-to-equity ratio, which is essential in understanding the companys capital structure and potential risks. The companys ability to generate cash from operations, as measured by its operating cash flow margin, is also vital. Furthermore, the price-to-book (P/B) ratio can provide insights into the companys valuation relative to its book value. With a market capitalization of $3.48 billion, Plexus Corp is a mid-cap stock, and its valuation multiples, such as the price-to-earnings (P/E) ratio of 21.89, should be evaluated in the context of industry peers.
From a growth perspective, Plexus Corps revenue growth rate and its ability to expand its customer base across various sectors are critical factors. The companys focus on high-mix, low-volume manufacturing and its expertise in producing complex products with high precision and reliability are key drivers of its growth. As the demand for EMS continues to rise, driven by the increasing complexity of electronic products and the need for manufacturers to reduce costs and improve efficiency, Plexus Corp is well-positioned to capitalize on these trends.
PLXS Stock Overview
| Market Cap in USD | 3,474m |
| Sub-Industry | Electronic Manufacturing Services |
| IPO / Inception | 1986-02-05 |
PLXS Stock Ratings
| Growth Rating | 31.5% |
| Fundamental | 55.0% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -8.33% |
| Analyst Rating | 3.80 of 5 |
PLXS Dividends
Currently no dividends paidPLXS Growth Ratios
| Growth Correlation 3m | -4.5% |
| Growth Correlation 12m | -32.1% |
| Growth Correlation 5y | 84.3% |
| CAGR 5y | 12.54% |
| CAGR/Max DD 5y | 0.36 |
| Sharpe Ratio 12m | 0.54 |
| Alpha | -13.27 |
| Beta | 1.310 |
| Volatility | 30.64% |
| Current Volume | 108.5k |
| Average Volume 20d | 131.7k |
| Stop Loss | 132.8 (-3.1%) |
| Signal | -1.90 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (162.7m TTM) > 0 and > 6% of Revenue (6% = 241.5m TTM) |
| FCFTA 978.9 (>2.0%) and ΔFCFTA 97.9kpp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 0.01% (prev 20.74%; Δ -20.74pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 1318 (>3.0%) and CFO 337.3m > Net Income 162.7m (YES >=105%, WARN >=100%) |
| Net Debt (-69.0k) to EBITDA (204.7m) ratio: -0.00 <= 3.0 (WARN <= 3.5) |
| Current Ratio -3.56 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (27.5m) change vs 12m ago -0.84% (target <= -2.0% for YES) |
| Gross Margin 10.18% (prev 9.30%; Δ 0.87pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 253.9% (prev 124.1%; Δ 129.8pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 14.97 (EBITDA TTM 204.7m / Interest Expense TTM 9.77m) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 55.03
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 6.93% = 3.46 |
| 3. FCF Margin 6.23% = 1.56 |
| 4. Debt/Equity 0.10 = 2.49 |
| 5. Debt/Ebitda 0.70 = 2.13 |
| 6. ROIC - WACC -2.24% = -2.80 |
| 7. RoE 12.02% = 1.00 |
| 8. Rev. Trend -68.60% = -3.43 |
| 9. Rev. CAGR -3.52% = -0.59 |
| 10. EPS Trend 2.96% = 0.07 |
| 11. EPS CAGR -3.03% = -0.38 |
What is the price of PLXS shares?
Over the past week, the price has changed by -0.18%, over one month by +6.61%, over three months by +4.01% and over the past year by +7.22%.
Is Plexus a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PLXS is around 133.35 USD . This means that PLXS is currently overvalued and has a potential downside of -2.67%.
Is PLXS a buy, sell or hold?
- Strong Buy: 1
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the PLXS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 154.6 | 12.8% |
| Analysts Target Price | 160.5 | 17.1% |
| ValueRay Target Price | 151.2 | 10.3% |
Last update: 2025-08-21 11:31
PLXS Fundamental Data Overview
CCE Cash And Equivalents = 69.0k USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 21.9276
P/S = 0.863
P/B = 2.4908
P/EG = 1.61
Beta = 0.797
Revenue TTM = 4.03b USD
EBIT TTM = 146.2m USD
EBITDA TTM = 204.7m USD
Long Term Debt = 92.2m USD (from longTermDebt, last quarter)
Short Term Debt = 50.7m USD (from shortLongTermDebt, last quarter)
Debt = 142.9m USD (Calculated: Short Term 50.7m + Long Term 92.2m)
Net Debt = -69.0k USD (from netDebt column, last quarter)
Enterprise Value = 3.62b USD (3.47b + Debt 142.9m - CCE 69.0k)
Interest Coverage Ratio = 14.97 (Ebit TTM 146.2m / Interest Expense TTM 9.77m)
FCF Yield = 6.93% (FCF TTM 250.6m / Enterprise Value 3.62b)
FCF Margin = 6.23% (FCF TTM 250.6m / Revenue TTM 4.03b)
Net Margin = 4.04% (Net Income TTM 162.7m / Revenue TTM 4.03b)
Gross Margin = 10.18% ((Revenue TTM 4.03b - Cost of Revenue TTM 3.62b) / Revenue TTM)
Tobins Q-Ratio = 1.86 (Enterprise Value 3.62b / Book Value Of Equity 1.94b)
Interest Expense / Debt = -1.75% (Interest Expense -2.50m / Debt 142.9m)
Taxrate = 13.68% (from yearly Income Tax Expense: 17.7m / 129.5m)
NOPAT = 126.2m (EBIT 146.2m * (1 - 13.68%))
Current Ratio = -3.56 (Total Current Assets 256.0k / Total Current Liabilities -72.0k)
Debt / Equity = 0.10 (Debt 142.9m / last Quarter total Stockholder Equity 1.42b)
Debt / EBITDA = 0.70 (Net Debt -69.0k / EBITDA 204.7m)
Debt / FCF = 0.57 (Debt 142.9m / FCF TTM 250.6m)
Total Stockholder Equity = 1.35b (last 4 quarters mean)
RoA = 63.5k% (set to none)
RoE = 12.02% (Net Income TTM 162.7m / Total Stockholder Equity 1.35b)
RoCE = 10.11% (Ebit 146.2m / (Equity 1.35b + L.T.Debt 92.2m))
RoIC = 8.11% (NOPAT 126.2m / Invested Capital 1.56b)
WACC = 10.35% (E(3.47b)/V(3.62b) * Re(10.84%)) + (D(142.9m)/V(3.62b) * Rd(-1.75%) * (1-Tc(0.14)))
Shares Correlation 5-Years: -100.0 | Cagr: -1.04%
Discount Rate = 10.84% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 59.84% ; FCFE base≈235.6m ; Y1≈159.7m ; Y5≈77.8m
Fair Price DCF = 37.83 (DCF Value 1.02b / Shares Outstanding 27.0m; 5y FCF grow -37.67% → 3.0% )
Revenue Correlation: -68.60 | Revenue CAGR: -3.52%
Rev Growth-of-Growth: 9.69
EPS Correlation: 2.96 | EPS CAGR: -3.03%
EPS Growth-of-Growth: 68.32
Additional Sources for PLXS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle